Dr. Eldad Uri Einav, MD

Dr. Einav practices at Beverly Hills Endosurgical Center in Beverly Hills, California.

Dr. Einav's NPI, 1851559041, was assigned on May 25, 2008. Dr. Einav graduated from The Hebrew University of Jerusalem Hadassah Medical School in 1996. Dr. Einav's California license number on file is C151846.

Dr. Einav's primary practice is Beverly Hills Endosurgical Center, at 150 North Robertson Blvd, Suite 110, Beverly Hills, CA 90211. The practice phone is (323) 202-2023.

Dr. Einav's primary practice is Beverly Hills Endosurgical Center in Beverly Hills, California. Dr. Einav is also affiliated with Westchester Medical Center. The medical group on file is Pacific Oaks Medical Group. Dmand AI also links Dr. Einav to 1 more hospital, 3 medical groups, 2 group practices and clinics and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Einav practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Einav's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Einav is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Einav's licenses on file in 4 states: California, New York, Nevada and Connecticut.

Dmand AI lists coronary artery disease, heart failure, high cholesterol and obesity among the conditions Dr. Einav treats.

CMS data shows 719 Medicare services from Dr. Einav across 5 procedure codes in 2024, for 504 Medicare patients. Medicare paid $18,671 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 504 Medicare patients who saw Dr. Einav in 2024. The largest group is 85 and over, with 154 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Einav's median patient age at 69, with 53% women.

In 2024, Dr. Einav wrote 332 Medicare Part D claims for 246 patients. CMS names the drug for 282 of them, across 7 drugs with 11 or more claims each, at $110,575 in total drug cost. In 2023, CMS named 6,546 claims across 12 drugs.

Dr. Einav accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Einav as offering telehealth.

Dmand AI links 4 papers to Dr. Einav, published from 2007 to 2024. 2007 was the busiest year, with 2. The most frequent topics are Endocarditis. Dr. Einav has published most often in J Am Soc Echocardiogr.

CMS Open Payments shows 219 general payments to Dr. Einav from 21 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 83% of the total. Novo Nordisk Inc paid the most, $194,058.

Dmand AI lists 1 award for Dr. Einav.

Dr. Einav graduated from The Hebrew University of Jerusalem Hadassah Medical School in 1996. Dr. Einav is a member of ACC.

Dr. Einav is in network with 21 carriers, including Aetna, MVP Health Care and United Healthcare. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.